RxDoctor Payments DataLook up a doctor →

Tanvir Bajwa, MD

Interventional Cardiology · Milwaukee, WINPI 1740257385

Payments from drug & device makers

$2,956,739in general payments, 2019–2025

Across 984 payments — averaging $3004.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2.2M
  • Boston Scientific$513K
  • Abbott$185K
  • W. L. Gore & Associates, Inc.$91K
  • Daiichi Sankyo Inc.$7K
  • Zimmer Biomet$4K
  • plus $6K from 8 others

What the payments were for

  • Consulting fees$24,11623%
  • Speaking & faculty fees$37,67336%
  • Grants$660%
  • Travel & lodging$31,55430%
  • Food & beverage$12,27012%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,956,739 in reported general payments places this provider in the 95th percentile of 118 interventional cardiology providers in Wisconsin.

See all interventional cardiology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$321,134
Medicare patients
1,055
Services billed
2,954

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban572$676,306
Repatha SureclickEvolocumab163$136,764
EntrestoSacubitril/Valsartan111$118,783
XareltoRivaroxaban90$116,848
JardianceEmpagliflozin82$102,869
BrilintaTicagrelor65$66,875
Praluent PenAlirocumab51$29,214
ClopidogrelClopidogrel Bisulfate1,256$15,425
Repatha SyringeEvolocumab16$13,585
Metoprolol Succinate757$11,527
Atorvastatin Calcium1,126$10,816
Nitroglycerin PatchNitroglycerin171$7,160
Isosorbide Dinit-HydralazineIsosorbide Dinit/Hydralazine36$4,916
Nitroglycerin278$4,600
Metoprolol Tartrate769$4,565

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →